MAP2K7 and Miyoshi myopathy: Subsequent molecular design refinement originated DTP3, that is a very high affinity and selective MKK7 binder, driving to a sustained JNK activation and consequent death of MM cell lines expressing GADD45β (as outlined in Figure 1).